LEX-WK-S5PCZ3HNcrawled 2018-07-25 17:41Z
FDA Releases Draft Guidance on Determining Whether to Submit an ANDA or a 505(b)(2) Application
Parithosh K. Tungaturthi, Ph.D. · BioLoquitur · Published December 4, 2017
Work details
- firm or organization
- Seyfarth Shaw LLP
- publication
- BioLoquitur
- practice area
- Food, Drug & Agriculture
- published
- 2017-12-04
Citation
Parithosh K. Tungaturthi, Ph.D., FDA Releases Draft Guidance on Determining Whether to Submit an ANDA or a 505(b)(2) Application, BioLoquitur (December 4, 2017) [The Library at LexBlog, LEX-WK-S5PCZ3HN, lexpid.org/S5PCZ3HN]